438 Shares in Encompass Health Co. (NYSE:EHC) Acquired by Transce3nd LLC

Transce3nd LLC acquired a new stake in shares of Encompass Health Co. (NYSE:EHC) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 438 shares of the company’s stock, valued at approximately $40,000.

Several other institutional investors and hedge funds have also recently modified their holdings of EHC. MassMutual Private Wealth & Trust FSB increased its holdings in Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after acquiring an additional 137 shares during the last quarter. CBIZ Investment Advisory Services LLC grew its position in shares of Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after purchasing an additional 127 shares in the last quarter. Tompkins Financial Corp bought a new stake in shares of Encompass Health in the fourth quarter worth about $46,000. V Square Quantitative Management LLC boosted its stake in Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock valued at $54,000 after buying an additional 177 shares during the last quarter. Finally, Signaturefd LLC grew its holdings in Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company’s stock valued at $65,000 after buying an additional 125 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Insiders Place Their Bets

In related news, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on EHC. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Barclays increased their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, February 7th. StockNews.com downgraded shares of Encompass Health from a “buy” rating to a “hold” rating in a report on Wednesday, April 16th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. Finally, KeyCorp boosted their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday, February 10th. One research analyst has rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and an average price target of $107.67.

Encompass Health Trading Up 2.9 %

EHC opened at $98.95 on Wednesday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The stock’s 50 day moving average price is $99.85 and its 200-day moving average price is $98.31. Encompass Health Co. has a one year low of $80.49 and a one year high of $104.55. The stock has a market cap of $9.96 billion, a price-to-earnings ratio of 22.19, a P/E/G ratio of 2.31 and a beta of 0.87.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, equities analysts forecast that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st were given a $0.17 dividend. The ex-dividend date was Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.69%. Encompass Health’s dividend payout ratio (DPR) is 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.